Chemotherapy Induced Anemia Market Size, Share & Trends 2031

Get free sample report Request for Customiztion Buy Now

Home
Healthcare
Healthcare & Pharmaceuticals
Chemotherapy Induced Anemia Market Size, Share & Trends 2031

Chemotherapy Induced Anemia Market Size, Share & Trends 2031

Segments - Chemotherapy Induced Anemia Market by Ranges of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, and Life-threatening Anemia), Treatment Types (RBC Transfusions, Iron Supplementation, and Erythropoiesis Stimulating Agents), Drug Types (Epogen Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, Procrit Injection, and Others), End-users (Ambulatory Surgical Centers, Hospitals, Multispecialty Clinics, Cancer Rehabilitation Centers, and Cancer Research Centers), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023-2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Chemotherapy Induced Anemia Market Outlook 2031

The global chemotherapy induced anemia market size was valued at USD 2.70 Billion in 2022 and is projected to reach USD 4.68 Billion by 2031, expanding at a CAGR of 6.3% during the forecast period, 2023-2031. The market growth is attributed to the increasing number of anemia cases among the geriatric population and the rise in the incidence of cancer.

Furthermore, several initiatives taken by various organizations to spread awareness among people regarding such diseases present a key aspect of the market. Anemia is a health condition when the total amount of red blood cells decreases in the blood or the red blood cells present in the body are dysfunctional.

Oxygen binds with red blood cells with the help of hemoglobin, which acts as an essential part. The different organs of the body do not get the required amount of oxygen when the number of red blood cells is low or abnormal. Common symptoms of anemia are shortness of breath, dizziness, fatigue, having a fast heartbeat, and skin pallor.

Anemia can be caused due to deficiency of iron or having low vitamin levels. When the normal tissues are invaded by malignant, it leads to blood loss. Deficiency of iron that is functional and disruption of erythropoiesis with bone marrow infiltration can result in chemotherapy induced anemia.

Crucial outcomes of chemotherapy cause chemotherapy induced anemia. When an individual is diagnosed with chemotherapy induced anemia, it is quite possible that it may cause a delay to the therapy and is also expected to result in dropping off the life quality and induces fatigue.

Chemotherapy Induced Anemia Market Trends, Drivers, Restraints, and Opportunities

Side effects caused by the treatment of cancer and the rise in the incidence of anemia in cancer patients due to several causes are expected to fuel the market growth.
Increasing chronic inflammatory conditions and invasion of bone marrow are some of the major factors anticipated to drive the market expansion in the coming years.
Advancement & innovation along with improvement in pipeline products are other key factors estimated to boost the market growth during the forecast period.
Risk associated with treatment and side effects caused due to drugs are key challenges that can restrain the growth of the market during the forecast period.
Presence of favorable reimbursement policies is projected to create lucrative opportunities for the growth of the market in the coming years.

Scope of Chemotherapy Induced Anemia Market Report

The report on the global chemotherapy induced anemia market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Chemotherapy Induced Anemia Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Ranges of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, and Life-threatening Anemia), Treatment Types (RBC Transfusions, Iron Supplementation, and Erythropoiesis Stimulating Agents), Drug Types (Epogen Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, Procrit Injection, and Others), and End-users (Ambulatory Surgical Centers, Hospitals, Multispecialty Clinics, Cancer Rehabilitation Centers, and Cancer Research Centers)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Pfizer Inc.; Panacea Biotec.; Therapure Biopharma Inc.; Panacea Biotec Limited; SBI Pharmaceuticals Co., Ltd.; 3SBio Inc.; Tolero Pharmaceuticals, Inc.; Vifor Pharma AG; and Dr. Reddy’s Laboratories Ltd.

Chemotherapy Induced Anemia Market Segment Insights

Ranges of Anemia Segment Analysis

Based on ranges of anemia, the global chemotherapy induced anemia market is divide into mild anemia, moderate anemia, severe anemia, and life-threatening anemia.

The severe anemia segment is projected to hold a key market share in the coming years owing to wide number of patients having this range group. Moreover, patients of this group are mostly recommended by medical professionals to undergo urgent chemotherapy technique to stop further spread of the disease.

Chemotherapy Induced Anemia Market Ranges of Anemia

Treatment Segment Analysis

On the basis of treatment types, the market is segregated into RBC transfusions, iron supplementation, and erythropoiesis stimulating agents. The RBC transfusions segment is a fast-growing domain and is anticipated to register a high CAGR during the forecast period owing to wide adoption of the treatment method as it is a first-line approach for the disease treatment.

Drug Types Segment Analysis

In terms of drug types, the global chemotherapy induced anemia market is categorized as epogen injection, androxy oral, aranesp injection, epoetin alfa injection, procrit injection, and others. The epogen injection segment is expected to grow substantially during the projected period owing to the high adoption and wide availability of the drugs.

Chemotherapy Induced Anemia Market Drug Type

End-users Segment Analysis

Based on end-users, the market is segmented into ambulatory surgical centers, hospitals, multispecialty clinics, cancer rehabilitation centers, and cancer research centers. The cancer research centers segment is anticipated to register a high CAGR during the forecast period owing to extensive research on the field and availability of advanced technology for chemotherapy techniques.

However, the hospitals segment is projected to account for a key market share in the coming years owing to easy accessibility of hospitals and presence of highly specialized doctors and medical staffs.

Regional Outlook

In terms of regions, the global chemotherapy induced anemia market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Asia Pacific held a large share of the market in 2019, which was followed by North America and Europe.

The market growth in Asia Pacific is expected to constitute a large market share during the forecast period attributed to innovations in the field of chemotherapy induced anemia, an enormous amount of awareness among people regarding such diseases, advancement of technologies for healthcare infrastructure, and initiatives taken by various governments in the region.

On the other hand, the market of Middle East & Africa is expected to grow at an extensive rate during the targeted period owing to increasing insubstantial expenditure for healthcare and the increasing number of people diagnosed with anemia in cancer patients.

Chemotherapy Induced Anemia Market Region

Segments

The global chemotherapy induced anemia market has been segmented on the basis of

Ranges of Anemia

Mild Anemia
Moderate Anemia
Severe Anemia
Life-threatening Anemia

Treatment Types

RBC Transfusions
Iron Supplementation
Erythropoiesis Stimulating Agents

Drug Types

Epogen Injection
Androxy Oral
Aranesp Injection
Epoetin Alfa Injection
Procrit Injection
Others

End-users

Ambulatory Surgical Centers
Hospitals
Multispecialty Clinics
Cancer Rehabilitation Centers
Cancer Research Centers

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Pfizer, Inc.
Clovis Oncology
Celgene Corp.
Amgen, Inc.
Novartis AG
PharmaCyte Biotech
F. Hoffmann-La Roche AG
IncTeva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Eli Lilly and Co.

Competitive Landscape

Key players competing in the global chemotherapy induced anemia market are Pfizer, Inc.; Clovis Oncology; Celgene Corp.; Amgen, Inc.; Novartis AG; PharmaCyte Biotech; F. Hoffmann-La Roche AG; IncTeva Pharmaceutical Industries Ltd.; Merck & Co., Inc.; and Eli Lilly and Co.

Many of these players have adopted business strategies such as the launch of new products, the advancement of technologies, mergers, partnerships, and production capacity expansion to increase their market position and expand their consumer base globally.

Chemotherapy Induced Anemia Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chemotherapy Induced Anemia Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Chemotherapy Induced Anemia Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Chemotherapy Induced Anemia Market - Supply Chain
  4.5. Global Chemotherapy Induced Anemia Market Forecast
     4.5.1. Chemotherapy Induced Anemia Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Chemotherapy Induced Anemia Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Chemotherapy Induced Anemia Market Absolute $ Opportunity
5. Global Chemotherapy Induced Anemia Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Chemotherapy Induced Anemia Market Size and Volume Forecast by End Users
     5.3.1. Ambulatory Surgical Centers
     5.3.2. Hospitals
     5.3.3. Multispecialty Clinics
     5.3.4. Cancer Rehabilitation Centers
     5.3.5. Cancer Research Centers
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Chemotherapy Induced Anemia Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Chemotherapy Induced Anemia Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Chemotherapy Induced Anemia Demand Share Forecast, 2019-2026
7. North America Chemotherapy Induced Anemia Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Chemotherapy Induced Anemia Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Chemotherapy Induced Anemia Market Size and Volume Forecast by End Users
     7.4.1. Ambulatory Surgical Centers
     7.4.2. Hospitals
     7.4.3. Multispecialty Clinics
     7.4.4. Cancer Rehabilitation Centers
     7.4.5. Cancer Research Centers
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Chemotherapy Induced Anemia Demand Share Forecast, 2019-2026
8. Latin America Chemotherapy Induced Anemia Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Chemotherapy Induced Anemia Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Chemotherapy Induced Anemia Market Size and Volume Forecast by End Users
     8.4.1. Ambulatory Surgical Centers
     8.4.2. Hospitals
     8.4.3. Multispecialty Clinics
     8.4.4. Cancer Rehabilitation Centers
     8.4.5. Cancer Research Centers
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Chemotherapy Induced Anemia Demand Share Forecast, 2019-2026
9. Europe Chemotherapy Induced Anemia Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Chemotherapy Induced Anemia Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Chemotherapy Induced Anemia Market Size and Volume Forecast by End Users
     9.4.1. Ambulatory Surgical Centers
     9.4.2. Hospitals
     9.4.3. Multispecialty Clinics
     9.4.4. Cancer Rehabilitation Centers
     9.4.5. Cancer Research Centers
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Chemotherapy Induced Anemia Demand Share Forecast, 2019-2026
10. Asia Pacific Chemotherapy Induced Anemia Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Chemotherapy Induced Anemia Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Chemotherapy Induced Anemia Market Size and Volume Forecast by End Users
     10.4.1. Ambulatory Surgical Centers
     10.4.2. Hospitals
     10.4.3. Multispecialty Clinics
     10.4.4. Cancer Rehabilitation Centers
     10.4.5. Cancer Research Centers
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Chemotherapy Induced Anemia Demand Share Forecast, 2019-2026
11. Middle East & Africa Chemotherapy Induced Anemia Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Chemotherapy Induced Anemia Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Chemotherapy Induced Anemia Market Size and Volume Forecast by End Users
     11.4.1. Ambulatory Surgical Centers
     11.4.2. Hospitals
     11.4.3. Multispecialty Clinics
     11.4.4. Cancer Rehabilitation Centers
     11.4.5. Cancer Research Centers
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Chemotherapy Induced Anemia Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Chemotherapy Induced Anemia Market: Market Share Analysis
  12.2. Chemotherapy Induced Anemia Distributors and Customers
  12.3. Chemotherapy Induced Anemia Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Pfizer, Inc.
     12.4.2. Clovis Oncology
     12.4.3. Celgene Corp.
     12.4.4. Amgen, Inc.
     12.4.5. Novartis AG
     12.4.6. PharmaCyte Biotech